| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/NEUR.1996.0022 |
| P698 | PubMed publication ID | 8819136 |
| P2093 | author name string | Luiten PG | |
| Nyakas C | |||
| Bakker R | |||
| Douma BR | |||
| Stuiver BT | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 153-159 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | In vivo protection against NMDA-induced neurodegeneration by MK-801 and nimodipine: combined therapy and temporal course of protection | |
| P478 | volume | 5 |
| Q33995061 | A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke. |
| Q28213885 | Activation of NMDA receptors and L-type voltage-gated calcium channels mediates enhanced formation of Fyn-PSD95-NR2A complex after transient brain ischemia |
| Q42922061 | Adaptation to intermittent hypoxia restricts nitric oxide overproduction and prevents beta-amyloid toxicity in rat brain |
| Q48496056 | Beta-amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: reversal by NMDA receptor blockade. |
| Q48658080 | Calcium channel density and hippocampal cell death with age in long-term culture. |
| Q30583493 | Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? |
| Q48247563 | Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion |
| Q44880515 | Effects of nimodipine on the behavioral sequalae of experimental status epilepticus in prepubescent rats |
| Q46311550 | Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation |
| Q42495568 | Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine |
| Q48517846 | NGP1-01 is a brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels |
| Q48355270 | Neuroprotection against N-methyl-D-aspartate-induced excitotoxicity in rat magnocellular nucleus basalis by the 5-HT1A receptor agonist 8-OH-DPAT. |
| Q33809078 | Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease |
| Q42443871 | Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats |
| Q44061389 | Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities |
| Q42494630 | Postnatal treatment with ACTH-(4-9) analog ORG 2766 attenuates N-methyl-D-aspartate-induced excitotoxicity in rat nucleus basalis in adulthood. |
| Q36494558 | Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. |
| Q44253409 | Study of the protective effect of calcium channel blockers against neuronal damage induced by glutamate in cultured hippocampal neurons. |
| Q73109599 | The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism |
| Q73634858 | The use of nimodipine in the treatment of mood disorders |
| Q38100382 | Treatment of status epilepticus with ketamine, are we there yet? |
| Q42487412 | Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis. |
| Q43517443 | Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. |
| Q34117516 | Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis |
Search more.